| Reaction Details |
|---|
 | Report a problem with these data |
| Target | 26S proteasome non-ATPase regulatory subunit 14 |
|---|
| Ligand | BDBM88889 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay |
|---|
| IC50 | 6200±702 nM |
|---|
| Citation |  PubChem, PC Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay PubChem Bioassay(2012)[AID] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| 26S proteasome non-ATPase regulatory subunit 14 |
|---|
| Name: | 26S proteasome non-ATPase regulatory subunit 14 |
|---|
| Synonyms: | 26S Proteasome regulatory subunit Rpn11 (Rpn11) | POH1 | PSDE_HUMAN | PSMD14 | PSMD14 protein |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 34576.68 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O00487 |
|---|
| Residue: | 310 |
|---|
| Sequence: | MDRLLRLGGGMPGLGQGPPTDAPAVDTAEQVYISSLALLKMLKHGRAGVPMEVMGLMLGE
FVDDYTVRVIDVFAMPQSGTGVSVEAVDPVFQAKMLDMLKQTGRPEMVVGWYHSHPGFGC
WLSGVDINTQQSFEALSERAVAVVVDPIQSVKGKVVIDAFRLINANMMVLGHEPRQTTSN
LGHLNKPSIQALIHGLNRHYYSITINYRKNELEQKMLLNLHKKSWMEGLTLQDYSEHCKH
NESVVKEMLELAKNYNKAVEEEDKMTPEQLAIKNVGKQDPKRHLEEHVDVLMTSNIVQCL
AAMLDTVVFK
|
|
|
|---|
| BDBM88889 |
|---|
| n/a |
|---|
| Name | BDBM88889 |
|---|
| Synonyms: | MLS000409349 | N-(2-cyanophenyl)-2-[(4-keto-5,6-dimethyl-3H-thieno[2,3-d]pyrimidin-2-yl)methylthio]acetamide | N-(2-cyanophenyl)-2-[(5,6-dimethyl-4-oxidanylidene-3H-thieno[2,3-d]pyrimidin-2-yl)methylsulfanyl]ethanamide | N-(2-cyanophenyl)-2-[(5,6-dimethyl-4-oxo-3H-thieno[2,3-d]pyrimidin-2-yl)methylsulfanyl]acetamide | N-(2-cyanophenyl)-2-[(5,6-dimethyl-4-oxo-3H-thieno[2,3-d]pyrimidin-2-yl)methylthio]acetamide | SMR000247657 | cid_2544369 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C18H16N4O2S2 |
|---|
| Mol. Mass. | 384.475 |
|---|
| SMILES | Cc1sc2nc(CSCC(=O)Nc3ccccc3C#N)[nH]c(=O)c2c1C |
|---|
| Structure | 
|
|---|
Search and Browse
